Richard Hindley has seen an exceptionally large increase in consultations for men with BPH, following the NICE approval, in August 2018, of Rezum steam treatment for Benign Prostatic Hyperplasia (BPH). Richard is the lead surgeon in the UK for this pioneering new minimally invasive treatment. He continues to collate data on this treatment to monitor the efficacy and allow results to be followed and compared in medical trials. He is delighted to be able to offer this treatment in both London (HCA Princess Grace) and Hampshire (BMI The Hampshire Clinic). In 2018, Richard received the honour of Visiting Professor of Knowledge Exchange for Winchester University in the Health and Wellbeing Research Group and was also recently appointed as a Specialist Adviser to NICE’s Interventional Procedures Programme. Having qualified in Scotland at the University of Dundee, Richard spent his initial surgical training in Brighton before embarking on 6 years specialist Urology training based in the South Thames training region. This included 2 years at King’s Hospital before passing his final surgical exams and traveling to Brisbane for a laparoscopic urology fellowship in 2003.
He was later appointed as a consultant in Basingstoke in 2004. Since then he has spent the last 10 years developing the local service and his interests in minimally invasive treatments for urological conditions.
Richard is the clinical lead in Urology in his department at the North Hampshire Hospital. He has introduced cutting-edge treatments including the first centre outside of London offering day-case laser prostate surgery for BPH in 2005. He is also a recognised expert in prostate cancer diagnosis and focal treatment using technologies such as HIFU and Cryotherapy. Basingstoke is now one of the leading centres in the UK and receives referrals from across the South of England. He has very much been at the forefront of treatments for benign and malignant conditions of the prostate.
He is also a very experienced laparoscopic renal surgeon and is now using the Da Vinci robot for the treatment of kidney conditions.
Richard enjoys teaching and training and has helped to introduce laparoscopy, HIFU and Greenlight laser surgery to centres around the UK. He has a large research portfolio and is currently recruiting over 50 patients per year to prostate-related clinical trials.
He has recently been appointed as Chair of the GIRFT Academy for bladder outlet obstruction, which has been set up to improve the quality of care for men with symptomatic BPH and reduce regional variations in practice.
Selected publications from PubMed
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries.
Light A, Peters M, Gopalakrishnan A, Mayor N, Cullen E, Boaz RJ, Norris JM, Morris S, Arya M, Tanaka MB, Doherty A, Dudderidge T, Emara A, Emberton M, Grey A, Hindley R, Laniado M, McCraken S, Moore CM, Nigam R, Noureldin M, Orczyk C, Rakauskas A, Simmons L, Virdi J, Withington J, Zakikhani P, Ahmed HU, Shah TT
Eur Urol. 2026 Jul 10 pii: S0302-2838(26)02169-X. doi: 10.1016/j.eururo.2026.05.007.
AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study.
Sushentsev N, Arya Z, Budd J, Frary A, Moreira da Silva N, Ferrer Rodriguez M, Burn P, Hindley R, Vasdev N, Ibrahim M, Bradley A, Andreou A, Liyanage S, Persad R, Aning J, Ng ABCD, Asif A, Kasivisvanathan V, Barrett T, Hinton M, Padhani AR, Shah A, Davies L, Rix A, Sala E
Eur Radiol. 2026 Jul;36(7):5719-5727 doi: 10.1007/s00330-026-12361-6.
Water vapor thermotherapy and high-grade Clavien-Dindo complications: retrospective analysis of 10 cases.
Cindolo L, Minore A, Schwartzmann I, Alejo AF, Imperatore V, Iossa V, Ebbing J, Destefanis P, Hindley R, Emara A, Pastore A, Sequi MB, Balsamo R, Knazik R, Coscarella M, De Nunzio C, Secco S
World J Urol. 2026 May 28;44(1) pii: 392. doi: 10.1007/s00345-026-06495-x.
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.
Light A, Peters M, Arya M, Bertoncelli Tanaka M, Dudderidge T, Emara A, Emberton M, Grey A, Hindley R, Laniado M, McCraken S, Moore CM, Nigam R, Noureldin M, Orczyk C, Reddy D, Virdi J, Ahmed M, Albisinni S, Cathcart P, Joniau S, Karnes RJ, Persad R, Rajwa P, Sanchez-Salas R, Shariat SF, Smith JA, Tilki D, van der Poel H, Calleris G, Gontero P, Marra G, Ahmed HU, Shah TT
JAMA Oncol. 2026 Apr 1;12(4):364-373 doi: 10.1001/jamaoncol.2025.6448.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinoma.
Kok SY, Mohamed F, Moran BJ, Dayal S, Tzivanakis A, Hindley R, Emara A, Cecil T
J Surg Case Rep. 2026 Mar;2026(3):rjag170 doi: 10.1093/jscr/rjag170.
BPH is a pathological enlargement of the prostate gland. It is a very common disease affecting men over 50, with a prevalence of 90% in those over 80. The causes are not clear, but hormone changes are thought to play a role. Patients with BPH may present with symptoms that vary from mild to severe, and are commonly referred to as low obstructive urinary symptoms (weak urinary flow, nocturia, frequent urination, urgency, etc.). In this lecture, Professor Richard Hindley explains what are, currently, the alternatives to TURP procedures and the benefits they may have on BPH patients.
Published
Oct 2020
Management of symptomatic BPH is evolving and now includes several minimally invasive therapies which aim to improve urinary symptoms whilst maintaining a low likelihood of side-effects. Resection, vaporization and enucleation of prostate tissue allow for maximum tissue removal with excellent symptomatic benefits, but with a not insignificant risk of sexual dysfunction and incontinence. Furthermore, the side-effects of BPH medication may have been underestimated and some men would prefer to avoid taking medication. Rezūm is a novel interstitial therapy for BPH which uses convective heating to ablate prostate tissue. The 3-year results from a prospective randomized US trial have demonstrated encouraging and durable results with preservation of sexual function. It is quick and can be performed under local anesthetic. Rezūm uses the natural energy stored in water vapor, or steam. It is a safe and effective treatment available to relieve symptoms associated with benign prostatic hyperplasia, or BPH.
With Boston Scientific
Published
Jan 2020
Help your network discover Dr. Richard Hindley's clinical expertise.
